• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药品价格莫名其妙地上涨。

The inexplicable rise of medication prices.

作者信息

Balon Richard

机构信息

Department of Psychiatry and Behavioral Neurosciences and Anesthesiology, Wayne State University School of Medicine, Detroit, MI, USA. E-mail:

出版信息

Ann Clin Psychiatry. 2018 Aug;30(3):165-166.

PMID:30028889
Abstract

Prescription medications are now the fastest-growing medical costs. Prices of brand name medications are exorbitant. An example is long-acting injectable aripiprazole, which costs more than $2,400 for a single injection in the United States, while in Canada this cost is less than $500 and in Turkey it is approximately $150. That brings the annual cost to use this medication in the United States to approximately $30,000.

摘要

处方药如今是增长最快的医疗费用项目。品牌药价格过高。长效注射用阿立哌唑就是一个例子,在美国单次注射费用超过2400美元,而在加拿大该费用不到500美元,在土耳其约为150美元。这使得在美国使用这种药物的年费用约为3万美元。

相似文献

1
The inexplicable rise of medication prices.药品价格莫名其妙地上涨。
Ann Clin Psychiatry. 2018 Aug;30(3):165-166.
2
The effect of generic competition on the price of brand-name drugs.仿制药竞争对品牌药价格的影响。
Health Policy. 2004 Apr;68(1):47-54. doi: 10.1016/j.healthpol.2003.07.007.
3
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.美国处方药价格居高不下:根源与改革前景。
JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.
4
Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged.百布制药垄断:为何消费者总停在“豪华地段”以及游戏是如何被操纵的。
Am Univ Law Rev. 2016;66(1):247-303.
5
Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.第三方报销仿制药:在最高限价成本报销环境下,低于成本的报销盛行。
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4):421-425. doi: 10.1016/j.japh.2018.04.018. Epub 2018 May 31.
6
Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020.2015 年至 2020 年美国常见病症的品牌药物的美国批发价格的班内变化趋势。
JAMA Netw Open. 2021 Jan 4;4(1):e2035064. doi: 10.1001/jamanetworkopen.2020.35064.
7
OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.在美国销售的骨质疏松症药物:仿制药竞争、定价结构及支付方之间的差异
Int J Technol Assess Health Care. 2016 Jan;32(6):385-392. doi: 10.1017/S0266462316000623. Epub 2017 Jan 9.
8
Sending The Wrong Price Signal: Why Do Some Brand-Name Drugs Cost Medicare Beneficiaries Less Than Generics?发出错误的价格信号:为什么一些名牌药品对医疗保险受益人的价格低于仿制药?
Health Aff (Millwood). 2019 Jul;38(7):1188-1194. doi: 10.1377/hlthaff.2018.05476.
9
Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.通用竞争对阿托伐他汀处方和患者自付费用的影响。
JAMA Intern Med. 2016 Sep 1;176(9):1317-23. doi: 10.1001/jamainternmed.2016.3384.
10
Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.品牌药物和医疗保险部分 D:眼科护理提供者的处方模式如何影响成本。
Ophthalmology. 2018 Mar;125(3):332-339. doi: 10.1016/j.ophtha.2017.05.024. Epub 2017 Jun 16.

引用本文的文献

1
Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey.新加坡心力衰竭患者对药物费用讨论的患者体验与偏好:一项定性调查
Patient Prefer Adherence. 2025 Feb 22;19:407-418. doi: 10.2147/PPA.S502235. eCollection 2025.
2
The Role and the Effect of Magnesium in Mental Disorders: A Systematic Review.镁在精神障碍中的作用和影响:系统评价。
Nutrients. 2020 Jun 3;12(6):1661. doi: 10.3390/nu12061661.